Unknown

Dataset Information

0

Enhanced Cytotoxic Effect of Doxorubicin Conjugated to Glutathione-Stabilized Gold Nanoparticles in Canine Osteosarcoma-In Vitro Studies.


ABSTRACT: Osteosarcoma (OSA) is the most common malignant bone neoplasia in humans and dogs. In dogs, treatment consists of surgery in combination with chemotherapy (mostly carboplatin and/or doxorubicin (Dox)). Chemotherapy is often rendered ineffective by multidrug resistance. Previous studies have revealed that Dox conjugated with 4 nm glutathione-stabilized gold nanoparticles (Au-GSH-Dox) enhanced the anti-tumor activity and cytotoxicity of Dox in Dox-resistant feline fibrosarcoma cell lines exhibiting high P-glycoprotein (P-gp) activity. The present study investigated the influence of Au-GSH-Dox on the canine OSA cell line D17 and its relationship with P-gp activity. A human Dox-sensitive OSA cell line, U2OS, served as the negative control. Au-GSH-Dox, compared to free Dox, presented a greater cytotoxic effect on D17 (IC50 values for Au-GSH-Dox and Dox were 7.9 μg/mL and 15.2 μg/mL, respectively) but not on the U2OS cell line. All concentrations of Au-GSH (ranging from 10 to 1000 μg/mL) were non-toxic in both cell lines. Inhibition of the D17 cell line with 100 μM verapamil resulted in an increase in free Dox but not in intracellular Au-GSH-Dox. The results indicate that Au-GSH-Dox may act as an effective drug in canine OSA by bypassing P-gp.

SUBMITTER: Malek A 

PROVIDER: S-EPMC8227216 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC10451790 | biostudies-literature
| S-EPMC6271629 | biostudies-literature
| S-EPMC7922473 | biostudies-literature
2014-07-11 | GSE59284 | GEO
| S-EPMC5830607 | biostudies-literature
2014-07-11 | E-GEOD-59284 | biostudies-arrayexpress
| S-EPMC9322757 | biostudies-literature
| S-EPMC8395331 | biostudies-literature
| S-EPMC7894353 | biostudies-literature
| S-EPMC2736051 | biostudies-literature